Konstantinos Aprilakis

Konstantinos Aprilakis, M.D., is a Partner at Deerfield Management in New York, serving on the Therapeutics team since 2021. In this role, he is responsible for in-depth research and analysis of healthcare companies, with a strong focus on therapeutics and biotechnology sectors. Deerfield is a leading investment firm dedicated to healthcare, and Dr. Aprilakis plays a key role in sourcing, evaluating, and executing investments within this space.

Prior to joining Deerfield, Dr. Aprilakis built a distinguished career as a senior biotechnology analyst at Stifel Financial Corp., where he served as Managing Director, and previously at Deutsche Bank and Citizens JMP, covering public companies in the biotechnology sector. His analytical expertise and sector knowledge have positioned him as a trusted resource for life sciences investing, particularly in biotechnology therapeutics.

Dr. Aprilakis holds a Doctor of Medicine (M.D.) from Weill Cornell Medical College and a Bachelor of Arts in Philosophy (with a minor in Biology) from Stony Brook University. His background also includes biomedical research as a Howard Hughes Medical Institute scholar, contributing to his rigorous, science-driven investment approach in the healthcare and therapeutic industries.